Page 2 - Sanket Koul

Smartworks renews lease for 2.3 lakh sq ft office space in Hyderabad

Co-working and flex-space provider commits Rs 121 crore over five years for Hyderabad office space as it pursues expansion across key urban and Tier-I markets

Government bans 16 fixed drug combinations over health safety concerns

Health Ministry prohibits 16 fixed drug combinations, including antibiotic and cosmetic formulations, after an expert review found they lacked therapeutic justification and posed potential health risk

CDSCO prohibits clinical trials at KKR-backed HCG cancer hospital

Drug regulator alleges irregularities in reporting adverse events and conflict-of-interest disclosures by the unit's ethics committee during human clinical trials

Namo Cities: Delhi's decongestion dream faces the test of execution

Experts flag coordination gaps as Centre bets on transit-led satellite hubs

Target India signs ₹1,250-crore Bengaluru office lease for GCC expansion

The retailer's India arm has leased 8.3 lakh sq ft at Embassy Manyata Business Park, reinforcing Bengaluru's position as the leading hub for GCC-led office demand

Tulip Infratech plans ₹6,000 crore investment in Gurugram luxury housing

Developer launches Rs 1,100-crore Tulip Melrose project on Southern Peripheral Road as part of a larger luxury housing expansion plan

Govt's cough syrup move may shift rural demand towards Ayush remedies

The removal of cough syrups from Schedule K could make access more prescription-dependent in rural India, potentially shifting some demand towards Ayush products

Mumbai-based investor buys apartment in The Dahlias for ₹120 crore

The acquisition adds to a series of high-value transactions at DLF's super-luxury Gurugram project, where prices have risen sharply since launch

Maha FDA: Hospitals can't force patients to buy drugs from own pharmacies

The state regulator has directed hospitals and doctors to provide prescriptions directly to patients and allow them to buy medicines from any licensed pharmacy

Dr Reddy's launches generic oral leukaemia drug Bosutinib in US market

The company has launched a generic version of Pfizer's Bosulif for chronic myeloid leukaemia and secured 180 days of exclusivity for the 400 mg strength

Two key cancer drugs to cost 50% more amid continued supply disruptions

NPPA raises ceiling prices of key cancer drugs and select vaccines to address supply shortages and ensure continued availability of essential medicines

Realtors brace for project delays as Iran war disrupts supply chains

Developers brace for up to year-long project delays as the prolonged West Asia conflict raises costs, disrupts supplies and worsens labour shortages

Extended West Asia war threatens delivery of over 500,000 homes in India

Housing demand remains resilient and project financing is better than in previous cycles, says Anarock

Govt approves price hike for cancer drugs amid nationwide shortage

Clears way for higher rates for Cisplatin and Carboplatin amid supply crunch

Green SM leases 16,000 sq ft office space in Gurugram from Urban Vault

Vietnamese mobility firm expands workspace footprint as it scales its all-electric taxi service, with plans to add more facilities across the Delhi-NCR region

Lilly claims its oral GLP-1 outperformed oral semaglutide in diabetes trial

Drugmaker plans to submit orforglipron to USFDA for Type 2 diabetes approval by end of second quarter

Vertex Group to invest ₹300 crore in smart co-working centres over 3 years

Group launches full-stack smart co-working platform and plans to add 30-35 centres across 10 cities, targeting 50,000 seats nationwide

'India pharma resilient despite disruptions; no blanket price hike planned'

India's pharma sector remains resilient despite West Asia disruptions, as the government advances biopharma, R&D and bulk drug manufacturing initiatives

Scheme to build bulk drugs' R&D, capacity in works, says Pharma secy

India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs

Google leases 617,000 sq ft in Atrium Place, to pay ₹671 cr over 5 years

The lease includes a 15 per cent rent escalation every three years, the documents registered in April 2026 showed